Threatened Galapagos plants are focus of biologist's field guide

December 06, 1999

HARRISONBURG, Va. - They are found nowhere else in the world - and the last look we have at them may be in a new book written and photographed by a James Madison University assistant professor of biology.

"They" are some of the endemic plants of the Galàpagos, a 13-island archipelago off the coast of Ecuador made famous in 1845 by naturalist Charles Darwin. In imminent danger of extinction due to pressures exerted by man, these and other plants are depicted in Conley K. McMullen's comprehensive field guide, "Flowering Plants of the Galàpagos."

"Many plants native to these islands are tremendously threatened right now," McMullen said. "Some of them are found nowhere else in the world. To lose them because of interference by humans would be a tragedy."

McMullen, who first traveled to the Galàpagos in 1983 as a graduate student studying plant pollination, said some areas of native vegetation are being choked out by imported plants that thrive in the moderate island climate. Several plants that were introduced for human use or simply because they were pretty have slowly encroached on some of the less competitive endemic species and are now on the verge of eliminating them.

Many of these imported plants have no practical uses, he said.

"Even the quinine tree, which produces a treatment for malaria, is useless in the Galàpagos," McMullen said. "There is no malaria in the islands, but the tree is there in nearly uncontrollable numbers."

An additional threat comes from the many thousands of wild goats that populate a few of the major islands. Originally brought in by Ecuadorians seeking a life in the islands, these animals have voracious, non-discriminating appetites. To them, said McMullen, vegetation is vegetation, whether it's endangered or not.

And then there's man himself.

"Even though tourism to the islands has gone from about 18,000 visitors per year 16 years ago to approximately 70,000 per year today, it isn't really tourists who are trampling and destroying the vegetation," McMullen said. "Tourists travel along carefully plotted pathways. Not so the many Ecuadorians who come to the islands looking to make a living off the tourists."

McMullen said his book wasn't intended as an environmental manifesto, although it may well become that should the plants it details become extinct. Rather, he said, he wrote "Flowering Plants of the Galàpagos" as a practical, in-depth, yet compact guide to the plant life of the islands based on his fieldwork over the last 16 years.

While many reference works exist on the animal life of the Galàpagos, McMullen's book on the flora of the region is the only one of its kind and is geared toward both the layman and the scientist.

"On many of my trips to the islands, naturalist guides would ask me to accompany them on their trips," he said. "They knew plenty about the animals, but didn't know the plants, and it embarrassed them in front of tourists to not be able to answer questions. Now, with this book, both the guides and the tourists can get all the information they need about the plant life they see in the Galàpagos."

McMullen said protecting plant life in the Galàpagos is a concern of the Ecuadorian government, but one that is dictated by available funding. In the last few years the government has eliminated the goat population on one of the islands and pulled up or poisoned encroaching vegetation on others, but the problem is still overwhelming for a country that does not have unlimited resources.

"Some people might ask, 'why bother?'" McMullen said. "Certainly from a practical standpoint no one will miss some of the Galàpagos plants if they become extinct. But if we allow that to happen, we help reduce the wonderful diversity of life in nature. We impoverish ourselves and our world."

It was after conducting research in South America and the Gapàpagos Islands on the HMS Beagle from 1831 to 1836 that Darwin published his "Origin of Species," which proposed the theory of evolution.

"Flowering Plants of the Galàpagos" is published by Cornell University Press and contains a foreword by Sir Ghillean Prance, director of the Royal Botanic Gardens in the United Kingdom.
For further information, call Dr. Conley McMullen at 540-568-3805, or write him via e-mail at

NOTE: Two JMU-led groups will travel to the Galàpagos in 2000 for natural history tours of the archipelago.

In January, Dr. Norlyn Bodkin, retired professor of biology and director of the arboretum, will lead a group of arboretum supporters to the Galàpagos and the Amazon rain forest. In addition to an examination of the flora and fauna of these two areas, the 16-day tour will include a visit to the Ecuadorian capital of Quito.

From May 12-31, Dr. Conley McMullen, assistant professor of biology, will lead students to the Galàpagos for a study that will include such plant life as the cactus forests and "daisy" trees, and animals like giant tortoises, marine iguanas and penguins. The group, which will operate out of Quito, will also visit a number of historic sites on mainland Ecuador.

December 1999 Writer: Charles Culbertson, 540-568-3674

James Madison University

Related Malaria Articles from Brightsurf:

Clocking in with malaria parasites
Discovery of a malaria parasite's internal clock could lead to new treatment strategies.

Breakthrough in malaria research
An international scientific consortium led by the cell biologists Volker Heussler from the University of Bern and Oliver Billker from the UmeƄ University in Sweden has for the first time systematically investigated the genome of the malaria parasite Plasmodium throughout its life cycle in a large-scale experiment.

Scientists close in on malaria vaccine
Scientists have taken another big step forward towards developing a vaccine that's effective against the most severe forms of malaria.

New tool in fight against malaria
Modifying a class of molecules originally developed to treat the skin disease psoriasis could lead to a new malaria drug that is effective against malaria parasites resistant to currently available drugs.

Malaria expert warns of need for malaria drug to treat severe cases in US
The US each year sees more than 1,500 cases of malaria, and currently there is limited access to an intravenously administered (IV) drug needed for the more serious cases.

Monkey malaria breakthrough offers cure for relapsing malaria
A breakthrough in monkey malaria research by two University of Otago scientists could help scientists diagnose and treat a relapsing form of human malaria.

Getting to zero malaria cases in zanzibar
New research led by the Johns Hopkins Center for Communication Programs, Ifakara Health Institute and the Zanzibar Malaria Elimination Program suggests that a better understanding of human behavior at night -- when malaria mosquitoes are biting -- could be key to preventing lingering cases.

Widely used malaria treatment to prevent malaria in pregnant women
A global team of researchers, led by a research team at the Liverpool School of Tropical Medicine (LSTM), are calling for a review of drug-based strategies used to prevent malaria infections in pregnant women, in areas where there is widespread resistance to existing antimalarial medicines.

Protection against Malaria: A matter of balance
A balanced production of pro and anti-inflammatory cytokines at two years of age protects against clinical malaria in early childhood, according to a study led by ISGlobal, an institution supported by ''la Caixa'' Foundation.

The math of malaria
A new mathematical model for malaria shows how competition between parasite strains within a human host reduces the odds of drug resistance developing in a high-transmission setting.

Read More: Malaria News and Malaria Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to